179 related articles for article (PubMed ID: 6143491)
1. Antiherpes activity of some novel analogues of (E)-5-(2-bromovinyl)-2'-deoxyuridine (E-BrVUdR) in two different cell lines.
Reefschläger J; Bärwolff D; Herrmann G; Langen P
Acta Virol; 1984 Jan; 28(1):1-10. PubMed ID: 6143491
[TBL] [Abstract][Full Text] [Related]
2. Antiherpes activity of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil and some other 5-substituted uracil arabinosyl nucleosides in two different cell lines.
Reefschläger J; Herrmann G; Bärwolff D; Schwarz B; Cech D; Langen P
Antiviral Res; 1983 Sep; 3(3):175-87. PubMed ID: 6316849
[TBL] [Abstract][Full Text] [Related]
3. Differential antiherpes activity of the (E)-and (Z)-isomers of 5-(2-fluorovinyl)-2'-deoxyuridine (FVUdR).
Reefschläger J; Bärwolff D; Langen P
Acta Virol; 1984 Jul; 28(4):282-6. PubMed ID: 6148852
[TBL] [Abstract][Full Text] [Related]
4. Efficiency and selectivity of (E)-5-(2-bromovinyl)-2'-deoxyuridine and some other 5-substituted 2'-deoxypyrimidine nucleosides as anti-herpes agents.
Reefschläger J; Brwolff D; Bärwolff D; Langen P; Rosenthal HA
Antiviral Res; 1982 May; 2(1-2):41-52. PubMed ID: 6285818
[TBL] [Abstract][Full Text] [Related]
5. Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
Reefschläger J; Wutzler P; Thiel KD; Herrmann G
Antiviral Res; 1986 Mar; 6(2):83-93. PubMed ID: 3010858
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J
Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622
[TBL] [Abstract][Full Text] [Related]
7. [(E)-5-(2-bromovinyl)-2'-desoxyuridine--a new nucleoside analog with selective inhibitory action against herpesviruses. Studies in cell culture and animal experiments].
Reefschläger J; Wutzler P; Thiel KD; Töpke H; Bärwolff D; Langen P
Pharmazie; 1987 Jun; 42(6):407-11. PubMed ID: 2823299
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet.
Reefschläger J; Wutzler P; Thiel KD; Herrmann G
Pharm Res; 1987 Jun; 4(3):200-6. PubMed ID: 2855541
[TBL] [Abstract][Full Text] [Related]
9. Anti-herpes simplex virus and cytostatic activity of some new 5-substituted 1-(4-hydroxybutyl)-and 1-(2-hydroxyethoxymethyl) uracil nucleoside analogues.
Reefschläger J; Herrmann G; Jennrich H; Frost N
Acta Virol; 1985 May; 29(3):185-93. PubMed ID: 2864819
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice.
Reefschläger J; Wutzler P; Thiel KD; Bärwolff D; Langen P; Sprössig M; Rosenthal HA
Antiviral Res; 1982 Oct; 2(5):255-65. PubMed ID: 6295273
[TBL] [Abstract][Full Text] [Related]
11. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
Balzarini J; Bohman C; Walker RT; de Clercq E
Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
Rajcáni J; Reefschläger J
Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
[TBL] [Abstract][Full Text] [Related]
13. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA
Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides.
Zhou S; Breitenbach JM; Borysko KZ; Drach JC; Kern ER; Gullen E; Cheng YC; Zemlicka J
J Med Chem; 2004 Jan; 47(3):566-75. PubMed ID: 14736238
[TBL] [Abstract][Full Text] [Related]
15. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
Chou TC; Lopez C; Colacino JM; Feinberg A; Watanabe KA; Fox JJ; Philips FS
Mol Pharmacol; 1984 Nov; 26(3):587-93. PubMed ID: 6092904
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiviral properties of (Z)-5-(2-bromovinyl)-2'-deoxyuridine.
Jones AS; Rahim SG; Walker RT; De Clercq E
J Med Chem; 1981 Jun; 24(6):759-60. PubMed ID: 6265638
[TBL] [Abstract][Full Text] [Related]
17. Effects of various nucleosides on antiviral activity and metabolism of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus types 1 and 2.
Suzutani T; Machida H; Sakuma T; Azuma M
Antimicrob Agents Chemother; 1988 Oct; 32(10):1547-51. PubMed ID: 2847634
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activities of 4-O-(difluoromethyl)-5-substituted-uracil nucleoside analogues.
Reefschläger J; Pein CD; Cech D
J Med Chem; 1988 Feb; 31(2):393-7. PubMed ID: 2828623
[TBL] [Abstract][Full Text] [Related]
20. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]